01 12BDSI
02 2EMERGENT
03 2HARM REDUCTION THERP
04 6HIKMA
05 12INDIVIOR
06 59KALEO INC
07 52OREXO US INC
08 6PURDUE PHARMA LP
09 4ZMI PHARMA
01 27731686
02 37731690
03 27749194
04 37947017
05 38016788
06 28021344
07 38147866
08 28206360
09 28226610
10 28231573
11 68470361
12 48475832
13 28627816
14 68658198
15 38703177
16 28926594
17 38939943
18 68940330
19 39022022
20 39073933
21 29238108
22 69259421
23 29278182
24 69439900
25 39474869
26 19480644
27 29517307
28 39522188
29 39522919
30 39655843
31 49687454
32 19707226
33 29724471
34 19814838
35 210143792
36 110143972
37 210220158
38 310322239
39 310335549
40 110722510
41 110874661
42 610946010
43 210960155
44 110973814
45 111020343
46 411020387
47 611020388
48 111027072
49 111135155
50 411135216
51 511433066
52 311571518
53 311590286
54 111617713
55 111628139
56 111806428
57 111975096
01 6Y
02 149Blank
01 140Y
02 15Blank
01 32025-01-15
02 32025-03-21
03 62025-03-30
04 32025-04-30
05 22026-02-01
06 22026-03-31
07 12026-06-01
08 12026-06-10
09 22026-06-25
10 32026-12-12
11 22027-02-20
12 22027-02-27
13 22027-05-23
14 62027-07-23
15 62027-12-03
16 32028-03-12
17 22028-10-30
18 22028-11-25
19 22029-04-10
20 82029-08-07
21 22029-11-02
22 42030-03-26
23 62030-05-22
24 132031-02-28
25 32031-05-24
26 22032-02-04
27 22032-05-11
28 32032-08-20
29 402032-09-18
30 22034-07-18
31 62034-08-26
32 22035-03-16
33 22035-03-20
34 32035-04-24
35 12039-05-24
36 32041-06-14
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
